Thrivent Financial for Lutherans
CDLX icon

Thrivent Financial for Lutherans’s Cardlytics CDLX Stock Holding History

Thrivent Financial for Lutherans’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,238
Closed -$1.36M – 2469
2021
Q1 		$1.36M Buy
+1,238
New +$1.63M ﹤0.01% 1674

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ACM
Alua Capital Management New York $1.13B AUM 8.41% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AA
Antipodean Advisors New York $19.5M AUM 6.21% 1-Year Est. Return

Thrivent Financial for Lutherans's CDLX Position: Q2 2021 in Review

Thrivent Financial for Lutherans sold out of Cardlytics (CDLX) in Q2 2021, closing a stake of 1,238 shares — an estimated $1.36M sold.

Thrivent Financial for Lutherans first reported a position in CDLX in Q1 2021 and held it in 1 quarter. The position peaked at $1.36M in Q1 2021. 189 funds tracked by Wall St. Rank hold CDLX as of Q2 2021.

  • Thrivent Financial for Lutherans reported no remaining Cardlytics position as of Q2 2021 after selling out during the quarter.
  • Thrivent Financial for Lutherans sold 1,238 Cardlytics shares in Q2 2021, an estimated $1.36M.
  • Thrivent Financial for Lutherans first reported a position in Cardlytics in Q1 2021 and held it in 1 quarter.
  • Thrivent Financial for Lutherans's Cardlytics position peaked at $1.36M in Q1 2021.
  • 189 funds tracked by Wall St. Rank held Cardlytics as of Q2 2021.

Based on Thrivent Financial for Lutherans's 13F filing for Q2 2021, filed 19 Aug 2021.